drugset
drugset / Trial / NCT00155233

Interaction Between Nalbuphine and Morphine in PCA

NCT00155233 ↗

Phase 4 Unknown 200 enrolled National Taiwan University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist 2. This study was designed to investigate the interaction between nalbuphine and morphine

Timeline

Start
2005-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified — —
Subject Nalbuphine Small molecule — —

Indications

No indication recorded.